Stem cells have great potential to form into different types of cells in the body. This advantage makes stem cell therapy stand out as one of the most revolutionary techniques of modern day healthcare and medical science industry. Autologous stem cell transplantation is a type of stem cell therapy wherein the cells are removed, preserved and later used for the same patient. Hematopoietic stem cells or blood forming cells are the most common types of cell transplantation along with cardiac cells that are used for repairing the damage caused by heart attacks. Currently, the autologous stem cell market is at an interesting position. According to the researchers who are constantly studying this industry are expecting great rise in demand, applications and breakthroughs in the market.
For More Information Ask for Free Brochure @ http://www.marketsandmarkets.com/pdfdownload.asp?id=837
Autologous Stem Cell Market Segments
Autologous cell therapy market is largely segmented into two sections, namely, stem cell and non-stem cell based therapies. Both these types of therapies are evolving to be vital for the treatment of various diseases and disorders categorized under cancer, neurodegenerative diseases, skin diseases, cardiovascular diseases and various infectious diseases. Apart from applications based on the types of diseases, the market for autologous stem cells is also segmented based on the demand patterns across various geographic locations. These geographic regions include Latin America, North America, Europe, Asia Pacific and Middle East and Africa.
Forecasting reports from 2013 to 2017
Autologous stem cell market is gaining recognition as a platform for novel therapeutic techniques. As a result, the market is making remarkable growth in the field of regenerative medicines. Regulations put on by from higher authorities are helping the components of the market to come up with advanced techniques and improve effects of the existing therapies. These authorities along with governments from different countries are making constant efforts to bring stem cell therapies into mainstream medical treatments, which are inexpensive, safe, quick, deliverable and least painful. As a result, the market is also aiming at technological advancements in order to develop the existing conditions.
Based on market research reports, autologous stem cell market is expected to grow at a CAGR of 21% from 2012 to 2017. At this estimated rate, the ACT market will become worth more than $2.2 billion by the end of 2017. Based on geographic demands and innovative technologies, North America is currently leading the global market. However, emerging markets like Asia Pacific is also expected to make impressive growth during the forecasted period. Latin American countries like Mexico and Brazil will also show significant growth in treatments of diabetes and skin transplantation with autologous stem cells.